Login / Signup

Pritelivir for recurrent aciclovir-resistant herpes simplex virus 2 infections in immunocompromised patients.

Alexandra SerrisAnne PouvaretClémence LoiseauHanene AbidSonia BurrelJacques FourgeaudClaire RouzaudFanny LanternierDavid BoutolleauPierre Frange
Published in: The Journal of antimicrobial chemotherapy (2022)
Keyphrases
  • herpes simplex virus
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • intensive care unit
  • patient reported